A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
TAG’s Cheat Sheets for Tuberculosis Activists are designed to help advocates navigate the range of tools in use and in the research pipeline.
To help advocates stay up to date, Treatment Action Group (TAG) organized a series of virtual trainings on the diagnosis, treatment, care and support of people with drug-resistant TB, designed for community and civil society organizations.
This year’s edition of TAGline takes stock of the state of the HIV, TB, and HCV pandemics worldwide, and advances bold visions for what a future without them must look like.
The 1/4/6x24 Campaign warns that regimens to treat drug-resistant TB recently recommended by World Health Organization (WHO) and important diagnostic tools will remain out of reach due to high prices.
By Lizzy Lovinger and Mark Harrington This November’s U.S. election provides an opportunity for activists to pause and assess our approach to policy. We face some unprecedented roadblocks on our path to end HIV, hepatitis C virus (HCV), and tuberculosis…
By Mike Frick and Gisa Dang Background Two years into the COVID-19 pandemic, governments embarked on a journey to create a Pandemic Agreement, negotiated among member states of the World Health Organization (WHO), that would establish binding rules on how…
By Joelle Dountio Ofimboudem The hepatitis C Virus (HCV) remains one of the deadliest infectious diseases, despite the existence of an effective eight- to-twelve week cure. Still, of the 50 million people estimated to be living with HCV worldwide, 36…
By Wilson Kutamba and Richard Musisi With an estimated TB incidence of 200 cases per 100,000, Uganda is one of the 30 countries with the highest burden of TB/HIV globally. For the estimated 86,000 people living here who fell ill…